Coordination and management of a large multicenter screening trial: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

被引:17
作者
O'Brien, B
Nichaman, L
Browne, JEH
Levin, DL
Prorok, PC
Gohagan, JK
Sullivan, D
机构
[1] NCI, Div Canc Prevent, Early Detect Res Grp, EPN 330, Bethesda, MD 20892 USA
[2] NCI, Div Canc Prevent, Biometry Res Grp, Bethesda, MD 20892 USA
[3] Westat Inc, Rockville, MD USA
来源
CONTROLLED CLINICAL TRIALS | 2000年 / 21卷 / 06期
关键词
multicenter clinical trials; data collection; screening; cancer; coordination; operations; management;
D O I
10.1016/S0197-2456(00)00099-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial is a large and complex multi-institutional, multifaceted organization with a 20-year horizon. The implementation of the trial began with the creation of an organizational structure that supports strong leadership, cooperation, and effective communication among the trial collaborators including an operational framework for the development, review, and pretest of instruments, data collection, and management procedures; the setting of high-quality standards for training of trial staff; and the development of a comprehensive assessment plan for evaluation of all trial activities. This paper describes the process and methods used in the coordination and management of the PLCO trial. These include the role of the steering committee and its subcommittees and working groups, the establishment of regular and ad hoc communications among collaborators, the training of screening center coordinators and examiners, the PLCO manual of operations and procedures, and the development and implementation of a comprehensive quality assurance plan. Control Clin Trials 2000;21:310S-328S (C) Elsevier Science Inc. 2000.
引用
收藏
页码:310S / 328S
页数:19
相关论文
共 4 条
[1]   Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].
Hasson, MA ;
Fagerstrom, RM ;
Kahane, DC ;
Walsh, JH ;
Myers, MH ;
Caughman, C ;
Wenzel, B ;
Haralson, JC ;
Flickinger, LM ;
Turner, LM .
CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :329S-348S
[2]   Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].
Hayes, RB ;
Reding, D ;
Kopp, W ;
Subar, AF ;
Bhat, N ;
Rothman, N ;
Caporaso, N ;
Ziegler, RG ;
Johnson, CC ;
Weissfeld, JL ;
Hoover, RN ;
Hartge, P ;
Palace, C ;
Gohagan, JK .
CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :349S-355S
[3]   Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].
Prorok, PC ;
Andriole, GL ;
Bresalier, RS ;
Buys, SS ;
Chia, D ;
Crawford, ED ;
Fogel, R ;
Gelmann, EP ;
Gilbert, F ;
Hasson, MA ;
Hayes, RB ;
Johnson, CC ;
Mandel, JS ;
Oberman, A ;
O'Brien, B ;
Oken, MM ;
Rafla, S ;
Reding, D ;
Rutt, W ;
Weissfeld, JL ;
Yokochi, L ;
Gohagan, JK .
CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :273S-309S
[4]   Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].
Weissfeld, JL ;
Fagerstrom, RM ;
O'Brien, B .
CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :390S-399S